Recent Posts

FDA approves Lipfendra as first oral PCSK9 inhibitor for cholesterol

NEWYou can now listen to Fox News articles! Millions of Americans with high cholesterol now have a new treatment option, as the FDA has approved the first once-daily oral PCSK9 inhibitor. Merck, the New Jersey-based manufacturer of Lipfendra (enlicitide), announced the approval on Thursday. Lipfendra blocks the action of PCSK9, …

Read More »
The Ultimate Managed Hosting Platform